United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation
||March 24, 2020
||US District Court for the Southern District of New York
||Foley Square Office
|Nature of Suit:
||Other Statutes: False Claims Act
|Cause of Action:
||31:3729 False Claims Act
Access additional case information on PACER
Available Case Documents
The following documents for this case are available for you to view or download:
|March 24, 2020
OPINION & ORDER re: 28 MOTION to Dismiss ("Notice Of Novartis Pharmaceuticals Corporation's Motion To Dismiss Relator's Amended Complaint"), filed by Novartis Pharmaceuticals Corporation. For the foregoing reason s, the Court grants Novartis' motion to dismiss, pursuant to Rule 9(b), and grants Relator leave to amend his complaint by May 8, 2020, to comply with Rule 9(b)'s requirements. SO ORDERED. (Signed by Judge Kimba M. Wood on 3/24/2020) (va)
Use the links below to access additional information about this case on the US Court's PACER system.
A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?